A nationwide study of three invasive treatments for trigeminal neuralgia  by Koopman, Joseph S.H.A. et al.
PAIN

152 (2011) 507–513
www.e l sev ie r . com/ loca t e / pa inA nationwide study of three invasive treatments for trigeminal neuralgia
Joseph S.H.A. Koopman a,e,⇑, Laura M. de Vries b,c, Jeanne P. Dieleman a, Frank J. Huygen d,
Bruno H.Ch. Stricker a,b,c, Miriam C.J.M. Sturkenbooma,b
aDepartment of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
bDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
cDepartment of Pharmaceutical Affairs and Medical Technology, Health Care Inspectorate, The Hague, The Netherlands
dDepartment of Pain Treatment, Erasmus University Medical Center, Rotterdam, The Netherlands
eDepartment of Anesthesiology, Erasmus University Medical Center, Rotterdam, The Netherlands
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
a r t i c l e i n f oArticle history:
Received 23 December 2009
Received in revised form 21 October 2010
Accepted 29 October 2010
Keywords:
Percutaneous radiofrequency
thermocoagulation
Microvascular decompression
Partial sensory rhizotomy
Complication rate
Effectiveness
Cohort study0304-3959  2010 International Association for the
doi:10.1016/j.pain.2010.10.049
⇑ Corresponding author. Address: Department of M
21.55, Erasmus University Medical Center, PO Box 20
Netherlands. Tel.: +31 10 7044133; fax: +31 10 7044
E-mail address: skoop29@gmail.com (J.S.H.A. Koopa b s t r a c t
Invasive procedures for treatment of trigeminal neuralgia (TGN) include percutaneous radiofrequency ther-
mocoagulation (PRT), partial sensory rhizotomy (PSR), and microvascular decompression (MVD). Using a
nationwide discharge registry from The Netherlands, we assessed the frequency of use and patient charac-
teristics, and evaluated treatment failure for each patient undergoing PRT, PSR, or MVD from January 2002
through December 2004. Only patients without a procedure in the year prior were included. Primary out-
come was readmission for repeat procedures for TGN or known complications within 1 year. Comparability
of patient populations was assessed through propensity scores based on hospital, age, sex, and comorbidity.
Conditional logistic regression matched on propensity score was used to calculate relative risks (RR) with
95% conﬁdence intervals (CIs) for repeat procedures or complications. During the study period, 672 patients
with TGN underwent PRT, 39 underwent PSR, and 87 underwent MVD. Hospital type was the predominant
determinant of procedure type; age, sex, and comorbidity were weak predictors. The RR for repeat proce-
dures for PSR was 0.21 (95% CI: 0.07 to 0.65) and for MVD was 0.13 (95% CI: 0.05 to 0.35) compared with
PRT (RR 1). For complications, the RR of PSR was 5.36 (95% CI: 1.46 to 19.64) and of MVD was 4.40 (95% CI:
1.44 to 13.42). Sex, urbanization, and comorbidity did not inﬂuence prognosis, but hospital and surgical vol-
ume did. In conclusion, although PSR and MVD are associated with a lower risk of repeat procedure than
PRT, they seem to be more prone to complications requiring hospital readmission.
 2010 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under the Elsevier OA license.1. Introduction surgical approach [11]. Partial sensory rhizotomy and PRT are bothTrigeminal neuralgia is a severe form of facial pain presenting
with paroxysmal, unilateral pain in 1 or more branches of the ﬁfth
cranial nerve [3]. It has an estimated annual incidence of 12.6 per
100,000 person-years [15]. It can be either idiopathic or secondary
to diseases such as tumors, infarction, and multiple sclerosis [2].
Idiopathic trigeminal neuralgia is currently hypothesized to be
caused by neurovascular contact between an aberrant vein or ar-
tery and the ﬁfth cranial nerve at the root entry zone [16]. The 3
most common invasive modalities for the treatment of idiopathic
trigeminal neuralgia are microvascular decompression (MVD), par-
tial sensory rhizotomy (PSR), and percutaneous radiofrequency
thermocoagulation (PRT). During MVD, a Teﬂon patch is placed
between the nerve and vascular structure using an open brainStudy of Pain Published by Elsevie.
edical Informatics, Room EE
40, 3000 CA, Rotterdam, The
722.
man).destructive techniques aiming to destroy a part of the Gasserian
ganglion by, respectively, a neurosurgical or a minimal invasive
roentgen-guided approach [38]. Other possible procedures include
glycerol injections, gamma-knife radiosurgery, and balloon decom-
pression. All procedures lack evidence of efﬁcacy in randomized
controlled trials [37].
Partial sensory rhizotomy is sometimes used as an alternative
for MVD if arterial contact cannot be found, but it is also an open
neurosurgical procedure with risks comparable to those of MVD
[36]. Although guidelines exist suggesting a longer duration of pain
freedom after MVD compared with PRT, this advice should be re-
garded as an expert opinion [7,9]. A literature study describing
long-term outcomes of individual treatment modalities indicates
that MVD has a better effectiveness than PRT, but also a higher rate
of adverse events [31]. Studies included in this review concerned
mainly cohort studies of individual procedures with more than
5 years of follow-up. These studies, however, have not been per-
formed in 1 data source and therefore do not allow for a direct
comparison of procedures.r B V. . Open access under the Elsevier OA license.
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ment modalities for trigeminal neuralgia in daily practice is not
known, and comparisonsof the safety and effectiveness of thediffer-
ent treatment modalities on a population-based scale are lacking.
Direct comparisons between the treatment modalities using 1 data
source have not been reported. Furthermore, reports on prognostic
factors for the success rate of individual treatment modalities re-
main contradictory [32]. To describe the frequency of use of MVD,
PSR, and PRT and to compare the complication and failure rate of
thesemodalities on anationwide scale,weperformeda cohort study
using a database with hospital discharge diagnoses with complete
coverage of the population in The Netherlands.2. Materials and methods
2.1. Source population
Data were retrieved from a nationwide electronic database with
hospital discharge records that covers admissions in all general and
universitymedical centers in TheNetherlands (LandelijkeMedische
Registratie). The database includes, among others, demographics,
date of admissionanddischarge,main intervention (coded),medical
specialist (coded), and the main and secondary diagnoses at dis-
charge, based on the International Classiﬁcation of Diseases, 8th
Revision, Clinical Modiﬁcation (ICD-9-CM) coding system [17].
Characteristics of hospitalizations are recorded by medical special-
ists or residents and coded by professional code clerks on the basis
of hospital discharge letters. For every admission, 1 discharge/main
diagnosis (mandatory), and up to 9 secondary diagnoses (optional)
are registered. This is done similarly for interventions. The coding
is independent of reimbursement of hospital or specialist. Patients
and hospitals are anonymized to allow for secondary use and pro-
cessing of the data. All diagnoses are submitted in the same format,
mostly electronically. The database used for this study comprised
data from January 1, 2001, up to and including December 31, 2005.
More recent data are not available because of a change in the regis-
tration system in The Netherlands, which has resulted in incom-
pleteness of the registry after 2005.
2.2. Cohort deﬁnition
For incidence rate calculations, the study base comprised the
entire population of The Netherlands during the study period be-
tween January 1, 2002, and December 31, 2004. For all other anal-
yses, we generated a cohort of patients admitted for MVD (ICD-9
codes: 5-014.0), PSR (intervention code [ICD-9 codes]: 5-014.1, 5-
014.2) or PRT (ICD-9 codes: 5-043.2) all with trigeminal neuralgia
as the main diagnosis during the study period. Patients who had 1
of the procedures in the year prior to study entry were excluded
from the cohort. Each cohort member was followed up until the
earliest of one of the following events: admission for a complica-
tion, repeat procedure (any of the 3 studied) or end of a 1-year
follow-up period, whichever came ﬁrst.
2.3. Outcome deﬁnition
The primary outcome parameters in this study were frequency of
use, pluscomplicationsand treatment failure leading tohospital read-
missionwithin1 year of the initial admission.Complications included
hospitalizations for hearing loss, dysesthesia, persistent neurological
deﬁcit, death, cerebrospinal ﬂuid leakage, facial hypoesthesia,menin-
gitis, ataxia, hematoma, infarctions, pulmonary embolisms, herpes
labialis, vertigo, tinnitus, anacusis or hypoacusis, facial spasms, troch-
lear and acoustic palsy, facial paresis, severe brain damage, keratitis,
sensory loss, corneal hypoesthesia, arteriovenous ﬁstula, bleeding,loss of sight, corneal anesthesia, facial asymmetry and all ICD-9 codes
speciﬁcally specifying complications of procedures (Appendix A)
[10,11,14,20,22,29–31,33,36]. Complications were identiﬁed based
onthe ICD-9codesof themainor secondarydiagnoses.Treatment fail-
ure was deﬁned as a readmission for 1 of the studied procedures for
treatment of trigeminal neuralgia or for other reasons (eg, pharmaco-
logical treatment)with trigeminal neuralgiamentioned as primary or
secondary diagnosis. The indexdate for complications and failurewas
the date of hospital admission.
In addition to readmission rates for ﬁrst complication or repeat
procedure, we examined the duration of hospital stay for the initial
procedure (index hospitalization) and in-hospital mortality of the
index hospitalization as secondary outcomes. To evaluate compli-
cations and treatment failure after discharge, patients were linked
by patient number (same hospital) and sex, date of birth, and post-
al code (other hospitals).
2.4. Covariates
We considered the patient-related (age, sex, urbanization level,
comorbidity, type of specialist performing the procedure) and hos-
pital-related variables (surgical procedure volume per hospital,
type of hospital) as potential confounders and prognostic factors.
These factors might be related to treatment choice and outcome
based on either clinical judgment or literature. Urbanization was
chosen because it might reﬂect the accessibility to health care pro-
viders in the direct neighbourhood. The year prior to the index hos-
pitalization was used to assess the presence of comorbidity
(leading to hospital admission) on the basis of discharge diagnoses
during that year. Comorbidity was categorized according to the
Charlson comorbidity index adapted for ICD-9 CM [6,8]. During
the study period, there were 105 hospitals in The Netherlands, of
which 8 were university medical centers. To compare the experi-
ence with a speciﬁc procedure between hospitals, we classiﬁed
the surgical volume (ie, number of procedures performed) for each
procedure in each hospital into quintiles. Quintiles were based on
the distribution of surgical volumes in the population. A surgical
volume category of 1 meant that the hospital belonged to the
20% of hospitals with the lowest surgical volume in a certain pro-
cedure (including zero procedures). A score of 5 meant that the
hospital belonged to the group of 20% of hospitals with the highest
surgical volume. The scores related to the 3 different procedures
were then added together in an overall score ranging from 3 to
15, under the assumption that all types of procedures add to the
experience of hospitals and surgeons [11]. Urbanization of the
home address was evaluated using postal code data from Statistics
Netherlands [1]. Very urban indicated more than 2500 houses per
square kilometer. Moderately urban is between 1500 and 2500,
normal between 1000 and 1500, moderately rural between 500
and 1000, and very rural below 500 houses per square kilometer.
2.5. Analysis
For each treatment modality, we calculated the incidence rate
by dividing the number of procedures by the total Dutch popula-
tion for that year according to Statistics Netherlands [1].
Failure and complication risks were calculated for each type of
intervention at 1 month, 1 to 2 months, 2 to 3 months, and 3 to
12 months after the initial hospitalization by Kaplan–Meier analy-
sis. Rates of failure and complication were calculated by dividing
the number of readmissions by the total number of person-years
(patients could count multiple times). The 95% conﬁdence intervals
(95% CI) were calculated based on a binomial distribution.
To study whether we could compare outcomes between treat-
ment groups, we calculated propensity scores for each procedure
with PRT as the reference category [24]. Overlapping propensity
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ment groups, allowing for calculation of relative risks for complica-
tions and repeat procedures. Propensity scores were calculated for
each procedure separately. The following variables were included
in the model: the Charlson comorbidity score, sex, age, and the
type of treating hospital using logistical regression analysis. The ﬁ-
nal propensity score included all of these covariates for all proce-
dures. Because we expected the treating hospital to be a very
large predictor for type of procedure, we calculated a second pro-
pensity score model including age, sex, and chronic disease score.
Conditional logistic regression with matching on propensity score
(including age, sex, and comorbidity within bins of 0.1) was used
to yield relative risks (RR) for PSR and MVD. Percutaneous radiofre-
quency thermocoagulation was taken as the reference category. A
Cox proportional hazards model was used to analyze prognostic
factors for treatment failure.
A sensitivity analysis was performed including only the speciﬁc
complications described in the literature (all of the above except
the ICD-9 codes speciﬁcally specifying complications of proce-
dures) [10,11,14,20,22,29–31,33,36]. Furthermore, to ensure that
complications were attributable to the index hospitalization and
not to other interventions after the index hospitalization, a sensitiv-
ity analysis was performed in patients without hospitalizations be-
tween the index hospitalization and the ﬁrst complication. Further
sensitivity analyses included only patients who underwent surgery
in 2004, taking into account only complications and readmissions
stated as the primary discharge diagnosis (not as additional diagno-
ses). Hospitalization data only provide information on in-hospital
death, and death may impact on the failure rates. Therefore, we
conducted a survival analysis with imputed survival data to take
into account deaths occurring during follow-up. Survival data were
imputed using the age- and sex-speciﬁc mortality data of the gen-
eral Dutch population from 2003 as provided by Statistics Nether-
lands (CBS) [1]. Imputation of survival data was done using R
(version 2.7.12) (R Development Core Team, Vienna, Austria) [23].
Five possible dates of death were imputed based on age and sex.
The Kaplan–Meier analyses were redone using these imputed
survival data. In compliance with the method of multiple imputa-Table 1
Baseline characteristics.
Percutaneous radiofrequency
thermocoagulation (PRT)
N 672
Incidence rate/1.000.000 persons per year [95% CI] 13.8 [12.8; 14.9]
Average age (SD) 67.3 (12.9)
Male sex (%) 288 (42.8%)
Mean duration of ﬁrst Admission (SD) 1.52 (1.52)
Urbanization
Very urban 107 (16.2%)
Moderately urban 148 (22.4%)
Normal 122 (18.4%)
Moderately rural 150 (22.7%)
Very rural 135 (20.4%)
Comorbidity index*
0 (%) 640 (95.2%)
1 (%) 21 (3.1%)
2 (%) 4 (0.6%)
3 (%) 7 (1.0%)
Type of specialist
Neurosurgeon (%) 70 (10.4%)
Anesthesiologist (%) 601 (89.4%)
Other (%) 1 (0.2%)
Type of hospital
General (%) 653 (97.2%)
Academic (%) 19 (2.8%)
Between square brackets, the 95% conﬁdence interval is given. #chi-square analysis for
* The comorbidity index is based on the Charlson comorbidity score.tions, the rates and the standarderrorswereaveraged [25].All statis-
tical analyses were conducted in SPSS 15.0 (SPSS, Inc, Chicago, IL,
USA).
3. Results
3.1. Incidence
Between January 1, 2002, and December 31, 2004, 87 MVDs, 39
PSRs, and 672 PRTs were performed. The incidence rate of the 3
studied invasive procedures for trigeminal neuralgia in the Dutch
population was 16.4 per million persons per year (95% CI: 15.3 to
17.6) (Table 1). The rates were highest between the ages of 70
and 79 for all procedures, and the rate remained more or less stable
over calendar time (Fig. 1A and B).
3.2. Baseline characteristics
Patients undergoing an intervention for trigeminal neuralgia
during the study period were on average 65.8 years of age (SD
13.4), and a minority was male (43%) (Table 1). Patients were
generally healthy, with a mean Charlson comorbidity index score
of zero. The average number of procedures performed per hospi-
tal per year was 5.54 (SD 8.94). Percutaneous radiofrequency
thermocoagulation was the most widely applied procedure, with
a high average relative surgical volume level compared with that
of PSR and MVD (1.17, 0.44, and 0.31 procedures per hospital,
respectively). Finally, patients undergoing PRT were on average
older and had a shorter hospital stay than patients admitted
for the other procedures. There were large differences in hospital
and physician characteristics among the 3 procedures (Table 1).
3.3. Complications and therapeutic failure
In total, 33.8% of patients were readmitted for a repeat proce-
dure (2.4%) or a complication (31.6%) within 1 year after the initial
procedure (Table 2). The 1-year readmission risk derived from the
Kaplan–Meier analysis was 34% (95% CI: 30% to 37%) for all proce-Partial sensory
rhizotomy (PSR)
Microvascular
decompression (MVD)
Total posterior
fossa approach
P-value #
39 87 126 –
0.8 [0.6; 1.1] 1.8 [1.4; 2.2] 16.4 [15.3; 17.6]
58.0 (14.0) 57.8 (13.0) 57.9 (13.2) <0.01
15 (38.5%) 43 (49.4%) 58 (46.0%) 0.50
10.44 (6.55) 7.59 (2.55) 8.47 (4.39) <0.01
0.97
9 (23.1%) 10 (11.8%) 19 (15.3%)
14 (35.9%) 13 (15.3%) 27 (21.8%)
10 (25.6%) 16 (18.8%) 26 (21.0%)
6 (15.4%) 22 (25.9%) 28 (22.6%)
0 (0.0%) 24 (28.2%) 24 (19.4%)
0.31
39 (100.0%) 85 (97.7%) 124 (98.4%)
0 (0.0%) 1 (1.1%) 1 (0.8%)
0 (0.0%) 1 (1.1%) 1 (0.8%)
0 (0.0%) 0 (0.0%) 0 (0.0%)
<0.01
39 (100.0%) 86 (98.9%) 125 (99.2%)
0 (0.0%) 0 (0.0% 0 (0.0%)
0 (0.0%) 1 (1.1%) 1 (0.8%)
<0.01
12 (30.8%) 37 (42.5%) 49 (38.9%)
27 (69.2%) 50 (57.5%) 77 (61.1%)
categorical analysis, t-test for continuous variables.
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Fig. 1. (A) Incidence of individual treatments. The incidence per 1000,000 people per age category in The Netherlands. Treatments are applied more in older people, which is
to be expected because the incidence of trigeminal neuralgia increases with age. Neurovascular treatment is not used after the age of 80. (B) Incidence rate per calendar year.
The y-error bars display the 95% conﬁdence interval. The incidence rate of most treatment modalities is more or less stable over time. PRT, percutaneous radiofrequency
thermocoagulation; PSR, partial sensory rhizotomy; MVD, microvascular decompression.
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(9%, 95% CI: 3% to 15%) and highest for PRT (38%, 95% CI: 34% to
42%) (Table 2, Fig. 2).
Most complications occurred within the ﬁrst month (31.6%)
after the initial procedure. The risk of complications was lowest
for PRT (2% vs 8% and 6%). The majority of complications were
unspeciﬁc procedure complication codes (61%). Speciﬁed compli-
cations included Bell’s palsy (11%), infections (5%), anaphylactic
shock (6%), hemiplegia (6%), aspiration (6%), hematoma (6%), and
respiratory complications (6%). Most repeat procedures took place
between the third and ninth month (36.5%) after the initial
procedure.
A propensity score model based on hospital, age, sex, and
comorbidity could accurately predict which treatment was given(c statistic 0.99). There was, however, poor overlap. If hospital
was excluded from the propensity score, the model performed
worse (c-statistic 0.70) but there was considerable overlap, show-
ing that actually the hospital was important for the decision of
which treatment to perform and not so much the patient. After
matching on propensity score (not considering hospital), the rela-
tive risk of PSR for readmission (complications or repeat proce-
dures) was 0.40 [95% CI: 0.18 to 0.90], 5.36 [95% CI: 1.46 to
19.64] for complications and 0.21 [95% CI: 0.07 to 0.65] for repeat
procedures. Microvascular decompression had a relative risk of
0.25 [95% CI: 0.12 to 0.52] for total readmission, 4.40 [95% CI:
1.44 to 13.42] for complications and 0.13 [95% CI: 0.05 to 0.35]
for undergoing a repeat procedure. Most people undergoing a
PRT underwent a PRT as repeat procedure, whereas most people
Table 2
Characteristics of readmissions following initial procedure for trigeminal neuralgia.
PRT PSR MVD Total
Readmission total (%) 256 (100%) 6 (100%) 8 (100%) 270 (100%)
Complication (%) 11 (4.3%) 3 (50.0%) 5 (62.5%) 19 (7.0%)
Repeat procedure (%) 245 (95.7%) 3 (50.0) 4 (37.5%)a 252 (93.0%)a
Repeat procedure
Percutaneous Radiofrequency Thermocoagulation (%) 196 (80.0%) 0 (0.0%) 2 (50.0%) 198 (78.6%)
Partial Sensory Rhizotomy (%) 2 (0.8%) 2 (66.7%) 1 (25.0%) 5 (2.0%)
Microvascular Decompression (%) 6 (2.4%) 0 (0.0%) 1 (25.0%) 7 (2.8%)
Other or unspeciﬁed (%)b 41 (16.7%) 1 (33.3%) 0 (0.0%) 42 (16.7%)
One year readmission riskc 38 [34; 42] 15 [4; 27] 9 [3; 15] 34 [30; 37]
One year complication riskc 2 [1; 3] 8 [0; 16] 6 [1; 11] 3 [2; 4]
One year risk for repeat procedurec 37 [33; 41] 8 [0; 17] 5 [0; 9] 32 [29; 35]
This table displays the prevalence and type of readmission within one year according to type of initial procedure for trigeminal
neuralgia.
PRT, percutaneous radiofrequency thermocoagulation.
PSR, partial sensory rhizotomy.
MVD, microvascular decompression.
a There is one patient admitted for both a repeat procedure and a complication.
b Admission for trigeminal neuralgia without a speciﬁc intervention listed. A reason for readmission without intervention can be drug
treatment.
c Calculated by using Kaplan-Meier analysis with days from discharge until readmission as follow-up time. Between square brackets
are the 95% conﬁdence intervals. SD = standard deviation.
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Fig. 2. Survival curve. Of the 3 studied treatment modalities, the percutaneous
radiofrequency thermocoagulation had the highest risk of readmission. PRT,
percutaneous radiofrequency thermocoagulation; PSR, partial sensory rhizotomy;
MVD, microvascular decompression.
J.S.H.A. Koopman et al. / PAIN

152 (2011) 507–513 511undergoing a PSR underwent this procedure again as repeat
procedure. In contrast, after MVD most people had a PRT as second
procedure (Table 2).Sensitivity analyses considering only patients undergoing sur-
gery in 2004, or only healthy patients (Charlson comorbidity index
of zero), or only in literature-speciﬁed complications, or only main
diagnoses or using imputed survival data showed that the results
and conclusions did not materially change (P > .05).
Concerning our secondary outcomes, the admission duration of
the index hospitalization was 2.62 days (SD 3.38). No patients died
during the hospital stay (95% CI: 0.0% to 0.4%).
3.4. Prognostic factors
Sex, age, comorbidity, surgical volume, urbanization, and hospi-
tal (aggregated) were evaluated as prognostic factors for treatment
failure. Cox regression analysis, stratiﬁed by the type of ﬁrst proce-
dure, showed surgical volume and type of hospital to be associated
with failure (Table 3). Only the second and ﬁfth groups of surgical
volume were associated with an increased risk of failure (OR: 1.54,
95% CI: 1.10 to 2.16; and OR: 1.53, 95% CI: 1.07 to 2.20, respec-
tively). However, no clear volume-success relationship (ie, dose–
effect) could be shown. Being treated in a general hospital was
associated with an increased risk of failure (OR: 4.81, 95% CI:
2.47 to 9.34) compared with being treated in a university hospital.
There was no relationship between the comorbidity index, sex, age,
and being admitted for complications.
4. Discussion
This study showed that PRT was the most frequently applied
invasive procedure for trigeminal neuralgia, with 13.8 procedures
per 1 million person-years per calendar year. The rate of invasive
procedures did notmaterially change over time. Given an estimated
prevalence of trigeminal neuralgia in The Netherlands of 1600 per 1
million persons, approximately 1% of persons with trigeminal neu-
ralgia undergo a ﬁrst invasive procedure each year [27]. The type of
procedures performed were strongly hospital, age, and specialist
dependent. Partial sensory rhizotomy and MVD were more likely
to be carried out in specialized centers than PRT. Percutaneous
radiofrequency thermocoagulation was mostly performed by anes-
thesiologists, whereas PSR and MVD were almost exclusively car-
ried out by neurosurgeons. One MVD procedure was performed
by an ear/nose/throat specialist, although this might have reﬂected
a coding error. One would expect the duration of stay to be sim-
ilar for PSR and MVD because they are both neurosurgical proce-
Table 3
Prognostic factors.
PRT PSR MVD Total
Age 0.92 [0.72; 1.18] 1.30 [0.24; 7.08] 7.18 [0.88; 58.39] 1.01 [0.79; 1.28]
Sex 1.01 [1.00; 1.02] 0.96 [0.00; 1.02] 1.00 [0.95; 1.05] 1.01 [1; 1.02]
Comorbidity index
0 Ref NA Ref Ref
1 1.21 [0.62; 2.36] NA 0.05 [0.00; 1] 1.33 [0.68; 2.58]
2 4.19 [1.34; 13.12] NA 0.05 [0.00; 1] 2.92 [0.94; 9.13]
3 0.73 [0.18; 2.92] NA NA 0.85 [0.21; 3.4]
Hospital
University Ref Ref Ref Ref
General 4.56 [1.13; 18.32] 0.03 [0; 32.85] 10.35 [1.27; 84.12] 4.81 [2.47; 9.34]
Surgical volume
1 Ref NA Ref Ref
2 1.49 [1.06; 2.08] Ref 98257.15 [0.00; 1] 1.54 [1.1; 2.16]
3 0.76 [0.33; 1.78] 0.85 [0.05; 13.68] 86540.31 [0.00; 1] 0.8 [0.38; 1.68]
4 0.94 [0.60; 1.48] NA NA 0.99 [0.63; 1.56]
5 1.50 [1.04; 2.15] 1.42 [0.15; 13.64] NA 1.53 [1.07; 2.2]
6 0.49 [0.23; 1.02] 0.19 [0.01; 3.05] 15163.02 [0.00; 1] 0.29 [0.17; 0.52]
Urbanization
Very urban Ref Ref Ref Ref
Moderately urban 0.97 [0.66; 1.44] 0.59 [0.08; 4.20] 0.70 [0.10; 4.99] 0.94 [0.64; 1.36]
Normal 0.84 [0.55; 1.29] 0.43 [0.04; 4.80] 0.86 [0.14; 5.16] 0.82 [0.54; 1.22]
Moderately rural 0.88 [0.59; 1.31] 0.68 [0.06; 7.55] 0.20 [0.02; 2.19] 0.82 [0.56; 1.20]
Very rural 0.89 [0.59; 1.33] NA 0.00 [0.00; 1] 0.8 [0.54; 1.19]
In bold are the statistically signiﬁcant predictors of treatment failure. Ref is reference category, NA is not available (no cases in that
group).
PRT, Percutaneous radiofrequency thermocoagulation.
PSR, Partial sensory rhizotomy.
MVD, Microvascular decompression.
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less familiarity of the treating specialist (or hospital) with the
procedure. This latter might be reﬂected by the considerable dif-
ference in the absolute number of procedures performed. An-
other noteworthy ﬁnding was the high degree of patients
readmitted for unspeciﬁed repeat procedures. These might re-
ﬂect patients being admitted for drug treatment. One would ex-
pect less PSRs being performed because these are usually
reserved for patients in whom no neurovascular contact could
be shown. These operations might be performed in patients
who underwent a previous destructive procedure, thus lowering
the success rate of MVD. This is less likely because we selected
patients who were treatment naïve in the year preceding the in-
dex hospitalization. Alternatively, these patients might be se-
lected based on absence of neurovascular contact. Given the
spread in estimates of the presence of this contact, this might
be plausible [21,34,35].
Microvascular decompression had the lowest relative risk for
readmission (either complications or repeat procedures),mainly be-
cause of a lower risk for repeat procedures. Microvascular decom-
pression had, however, a higher complication risk compared with
PRT. Readmission was not associated with sex, urbanization, or
comorbidity,which is in linewith previous reports [26]. Itwas, how-
ever, positively associated with surgical volume (low and high) and
receiving treatment in a general hospital. A previous article reported
a higher complication rate in hospitals and surgeons with a lower
caseload [13]. Our ﬁnding that a lower caseload is associated with
readmission is in line with this study. The association between a
higher caseload and readmittancemight occur becausemore severe
or complicated patients are referred to the hospitals with a high
caseload. Our ﬁnding that younger patients more frequently under-
went MVD is in line with current practice [12]. This is presumably
attributable to the allegedly longer effect of MVD and presence of
comorbidity in older patients, which makes it difﬁcult to conduct
that intervention [12].
Percutaneous radiofrequency thermocoagulation showed the
lowest absolute complication rate but the highest failure rate,which is in line with recent reviews [5,28,31–33]. One study
compared MVD with PRT and reported an equal effect but a lower
long-term complication rate for MVD [18]. Our study shows a dif-
ference in effect, but this may be because we only assessed serious
complications requiring a readmission, which do not represent the
total range of adverse events. Assuming that neurosurgical inter-
ventions have a higher percentage of adverse events requiring hos-
pitalization, this will lead to a selective underestimation favoring
PRT. The high failure rate of PRT might have several causes. Com-
pared with MVD, which is usually performed by experienced neu-
rosurgeons, PRT is performed by less experienced doctors.
Furthermore, to avoid anesthesia dolorosa, doctors will be careful
not to apply too much coagulation. They prefer to conduct the pro-
cedure in 2 stages instead of risking adverse events. The low com-
plication rate of PRT is especially noteworthy because it is more
often performed in high-risk (older) patients.
5. Study limitations
Being an observational study using a hospital registry, we must
consider the inﬂuence of potential misclassiﬁcation and confound-
ing. There are several sources of misclassiﬁcation. Firstly, the failure
rate may be an underestimation because not every failure requires
readmission, as some recurrences may be treated conservatively.
Our study did not focus on failure that could be addressed in an out-
patient setting. Furthermore, it couldbehigher becausepatients dis-
satisﬁed after a procedure might not undergo a repeat procedure.
Given the lowereffectiveness of PRT, thismightgive rise toanunder-
estimation of the relative risk for readmittance. Secondly, admission
for complications after the interventionmay have been the result of
other hospitalizations during follow-up; this issue was explored by
exclusion of patients with other hospitalizations during follow-up.
This did not change the results substantially. Thirdly, because the
databaseonly captures in-hospital deathsandnotoutpatientdeaths,
people dying the year after readmission are lost to follow-up and
cannot count in the numerator, which may lead to an underestima-
tionof risks. Becauseof differences in age, this is less likely tohappen
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MVD are younger and thus less likely to die out of the hospital. To
minimize this bias, we imputed age- and sex-speciﬁc survival data
from the general Dutch population; the relative risk estimated did
not change substantially.
The fourth limitationof our study is the lownumberof prognostic
variables and the lack of speciﬁc prognostic factors such as disease
severity. We evaluated the type of hospital (university or general)
as a proxy for disease severity, duration of pain, etc., under the
assumption that the patient population of university hospitals (ter-
tiary centers) would differ from that of general hospitals (secondary
centers). Previous destructive surgery, a known risk factor for an
unfavorable outcome of MVD and PSR, could not be considered in
our analyses because we only had 1 year of history available
[11,36]. Patients undergoing a destructive procedure in that year
were excluded from the analysis to minimize possible confounding.
To further limit residual confoundingdue to the fact thatwehad lim-
ited prior history data, we performed a sensitivity analysis among
people undergoing a procedure in 2004. For these persons we had
3 years of prior history, and the results in these patientswere consis-
tent with the main analysis showing that residual confounding
caused by a short availability of information is limited. Several fac-
tors are known to be prognostic factors for failure of (neurosurgical)
procedures for trigeminal neuralgia. These include having a clear-
cut andmarkedvascular compression at surgery, type of vessel com-
pressing, duration of complaints, involvement of all 3 branches, and
postoperative pain relief [4,19,26,33,36]. Unfortunately these could
not be evaluated given the nature of our database.
Despite its limitations, the results of our study are unique in that
they capture a large nationwide study sample that provides a com-
prehensive overview of the application of invasive procedures for
trigeminal neuralgia in daily practice. The study further gives a valid
estimate of the absolute and relative risks (complications requiring
admission) and effectiveness (readmission for repeat procedure) of
individual surgical procedures in patientswith trigeminal neuralgia.
Previous reports showing a higher success rate of MVD compared
with PRT have now been conﬁrmed in a single data source. Finally,
we have shown that the choice for a certain treatment modality is,
at least in The Netherlands, a largely institutionalized practice and
not based on a nationwide consensus.Acknowledgements
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.pain.2010.10.049.
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